- Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
- Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants
- Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates
- Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer
- Genelux Corporation Reports Third Quarter 2023 Financial Results and Provides General Business Updates
- Genelux Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference
- Genelux Corporation Announces New Chief Financial Officer
- Genelux Corporation Reports Second Quarter 2023 Financial Results and Provides General Business Updates
More ▼
Key statistics
On Tuesday, Genelux Corp (GNLX:NAQ) closed at 2.79, 11.60% above the 52 week low of 2.50 set on May 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.70 |
---|---|
High | 2.86 |
Low | 2.63 |
Bid | 2.75 |
Offer | 2.79 |
Previous close | 2.79 |
Average volume | 620.39k |
---|---|
Shares outstanding | 33.87m |
Free float | 21.06m |
P/E (TTM) | -- |
Market cap | 94.50m USD |
EPS (TTM) | -0.9811 USD |
Data delayed at least 15 minutes, as of May 28 2024 21:00 BST.
More ▼